Jubilant Pharmova Limited has received a credit rating of IND AA+/Stable from India Ratings and Research Pvt Ltd for its proposed Non-Convertible Debentures (NCDs). The NCD issuance is for an amount of ₹1,400 crore. This rating indicates a strong capacity for timely payment of financial obligations.
Credit Rating Assigned for Proposed Debentures
Jubilant Pharmova Limited has announced that India Ratings and Research Pvt Ltd has assigned a credit rating to the company’s proposed Non-Convertible Debentures (NCDs). The assigned rating is IND AA+/Stable.
Issuance Details
The proposed issuance of these NCDs is for an aggregate amount of ₹1,400 crore. This rating signifies a strong capacity of the issuer to meet its financial commitments in terms of the obligation rated.
The rating communication was received by Jubilant Pharmova Limited on October 21, 2026, at 11:47 A.M. (IST). The company has also made this disclosure available on its website, www.jubilantpharmova.com.
Source: BSE
